JTC Employer Solutions Trustee’s Moderna MRNA Stock Holding History

JTC Employer Solutions Trustee’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21K	Hold	300	–	–	﹤0.01%	277
2026 Q1	$15K	Hold	300	–	–	﹤0.01%	275
2025 Q4	$9K	Hold	300	–	–	﹤0.01%	284
2025 Q3	$8K	Hold	300	–	–	﹤0.01%	287
2025 Q2	$8K	Hold	300	–	–	﹤0.01%	280
2025 Q1	$9K	Hold	300	–	–	﹤0.01%	287
2024 Q4	$12K	Sell	300 -1,500	-83%	-$71.7K	﹤0.01%	285
2024 Q3	$120K	Hold	1,800	–	–	0.01%	178
2024 Q2	$214K	Buy	1,800 +1,500	+500%	+$190K	0.01%	126
2024 Q1	$33K	Hold	300	–	–	﹤0.01%	275
2023 Q4	$30K	Hold	300	–	–	﹤0.01%	276
2023 Q3	$31K	Hold	300	–	–	﹤0.01%	279
2023 Q2	$36K	Hold	300	–	–	﹤0.01%	282
2023 Q1	$46K	Hold	300	–	–	﹤0.01%	268
2022 Q4	$54K	Hold	300	–	–	﹤0.01%	259
2022 Q3	$35K	Hold	300	–	–	0.01%	239
2022 Q2	$43K	Hold	300	–	–	0.01%	200
2022 Q1	$52K	Hold	300	–	–	0.01%	205
2021 Q4	$76K	Hold	300	–	–	0.01%	185
2021 Q3	$115K	Hold	300	–	–	0.02%	157
2021 Q2	$71K	Buy	+300	New	+$53.6K	0.01%	190

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

JTC Employer Solutions Trustee's MRNA Position: Q2 2026 in Review

JTC Employer Solutions Trustee held its Moderna (MRNA) position steady in Q2 2026 at 300 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

JTC Employer Solutions Trustee first reported a position in MRNA in Q2 2021 and has held it in 21 quarters since. The position peaked at $214K in Q2 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

JTC Employer Solutions Trustee held 300 shares of Moderna worth $21K as of Q2 2026.
JTC Employer Solutions Trustee left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #277 holding.
JTC Employer Solutions Trustee first reported a position in Moderna in Q2 2021 and has held it in 21 quarters since.
JTC Employer Solutions Trustee's Moderna position peaked at $214K in Q2 2024.
784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.